Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 815 results for "pfizer drugmaker pfizer"

UK drugmakers back in spotlight as bidders free to return

Restrictions on Pfizer and Stryker reviving their bid interest in AstraZeneca and Smith & Nephew will expire Yahoo! UK and Ireland, 4 days ago

12 images for pfizer drugmaker pfizer

Business Insider, 1 week ago
Reuters India, 1 week ago
New Europe, 1 week ago
Citybizlist, 1 week ago, 3 weeks ago
Pharmaceutical Technology, 1 week ago
Aurora Sentinel, 3 weeks ago
ABC News, 3 weeks ago
Daily Telegraph Australia, 1 month ago
One News Page United Kingdom, 1 month ago
New Europe

Pfizer, German drugmaker Merck partner on finding, developing immune-boosting cancer medicines

NEW YORK Pfizer says it will partner with German drug and chemical maker Merck in developing potential cancer drugs in a hot new medication class that harnesses the body's immune system to fight cancer. Under their agreement, New York-based ...
 FOXBusiness.com1 week ago US, German drugmakers team up on cancer medicines  Yahoo! UK and Ireland1 week ago U.S., German drugmakers team up on cancer medicines  Japan Today1 week ago

Pfizer signs $3 billion cancer deal

Pfizer has signed a multi-billion dollar deal to develop one of Merck KGaA's investigational drugs, MSB0010718C, an anti-PD-L1 antibody. The agreement could be worth nearly $3 billion to the German firm: $850 million up front from Pfizer and ...
 Pharmafocus1 week ago Pfizer, Germany's Merck KgaA Collaborate To Develop Cancer Drug - Update  RTTNews.com1 week ago German Merck, Pfizer in immunotherapy deal  CNBC1 week ago German Merck, Pfizer in cancer immunotherapy deal  Yahoo! UK and Ireland1 week ago

Merck Collaboration Rules Out AstraZeneca Acquisition--For Now

Summary Pfizer's multi-billion dollar agreement with Merck excludes either drugmaker from collaborating with other companies on the drug. This class of drugs happens to be one of AstraZeneca's main focuses. The collaboration is a risk for Pfizer, ...
 Seeking Alpha5 days ago UPDATE 1-Pfizer dampens Astra bid hopes by signing German Merck cancer deal  CNBC1 week ago Pfizer ends Astra bid hopes with Merck deal  Irish Examiner1 week ago Pfizer signs deal with Merck  The Gulf Today1 week ago
Finance 24

Pfizer: No new bid likely for AstraZeneca

London - Pfizer appears unlikely to make a fresh bid for AstraZeneca in 12 days time, when an enforced cooling-off period ends, and the US drugmaker is now weighing other less risky targets. People with direct knowledge of the situation said ...
 Finance 241 week ago Pfizer Looks to Targets Beyond AstraZeneca  FOXBusiness.com1 week ago AstraZeneca not only target for Pfizer  IOL1 week ago DEALTALK-AstraZeneca not only game in town for deal-hungry Pfizer  CNBC1 week ago

AstraZeneca On Track To Return To Growth By 2017, Confident Of Pipeline

UK-based drugmaker AstraZeneca Plc. (AZN.L,AZN: Quote), which earlier this year rejected an offer from US-based Pfizer Inc. (PFE), Tuesday said it is on track to return to growth by 2017, and that its pipeline is expected to drive strong and ...
 RTTNews.com1 week ago AstraZeneca Is Building Value Without Pfizer, CEO Says  Bloomberg2 weeks ago AstraZeneca PLC Is Building Value Without Pfizer: CEO  BioSpace2 weeks ago
Motley Fool

Will Pfizer's Dividend Be Safe?

Source: Pfizer via Facebook. Pfizer ( NYSE: PFE ) may be one of the planet's largest drugmakers, but it's been navigating a series of sales-crunching patent expirations that has investors wondering if the company's dividend payout will remain ...
 Motley Fool1 week ago
Pharmaceutical Technology

Pfizer agrees to supply contraceptive Sayana Press in poorer countries

US-based drugmaker Pfizer has signed an agreement with Bill & Melinda Gates Foundation and Children's Investment Fund Foundation (CIFF) to expand access to its injectable contraceptive, Sayana Press (medroxyprogesterone acetate), for women in poorer ...
 Pharmaceutical Technology1 week ago Pfizer, Gates Foundation, expand contraceptive access in poor nations  Yahoo! India1 week ago Low-cost and simple contraceptives for poor countries  The Africa Report1 week ago Pfizer, Bill and Melinda Gates Foundation, expand contraceptive access in poor nations  DNA India1 week ago
Motley Fool

3 Dividend Stocks Better Than Pfizer, Inc.

Pfizer ( NYSE: PFE ) reported third-quarter earnings this week that were generally underwhelming. The drugmaker announced that its sales sagged 2.2% to $12.36 billion and its adjusted EPS fell similarly by 2% year over year in the quarter.
 Motley Fool3 weeks ago Pfizer 3Q earnings up on emerging growth  USA Today4 weeks ago Pfizer's 3Q beats on emerging market growth  FOXBusiness.com4 weeks ago Pfizer beats Wall Street estimates with 3Q growth of drugs and vaccines in emerging markets  FOXBusiness.com4 weeks ago

AstraZeneca Raises Forecast as Nexium Competitor Fails to Appear

Nov. 6 (Bloomberg) -- AstraZeneca Plc, the U.K. drugmaker that fought off a takeover attempt by Pfizer Inc., raised its forecasts for the second time this year after competition for one of its top-selling medicines failed to materialize as expected.
 Washington Post3 weeks ago AstraZeneca Raises Forecast on Lack of Nexium Competitor  Bloomberg3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less